Cutaneous T-Cell Lymphoma Treatment Just Got Easier: UF Radiation Oncology’s Collaborative Solution To Minimize Patient Discomfort
UF Researchers have secured a provisional patent for a groundbreaking device that addresses the challenges of total skin electron beam therapy, a key treatment for cutaneous T-cell lymphoma.
Dialectic Therapeutics Announces DT2216 Has Received Orphan Drug Designation From the FDA for the Treatment of T-Cell Lymphoma
UF startup Dialectic Therapeutics, Inc. (Dialectic®), announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to DT2216 for the treatment of T-cell lymphoma.
